Ochrobactrum anthropi bacteremia: report of four cases and short review.
Ochrobactrum anthropi, formerly "Achromobacter" CDC group Vd, is a nonfermentative, nonfastidious gram-negative bacillus, that only recently has been given attention as a potential human pathogen. Over a 2-year period, we observed four patients with multiple blood cultures that were positive for the organism. The patients had acute leukemia as underlying disease, and presented with clinical and microbiologic features consistent with catheter-related bacteremia. In three of the patients the infection initially appeared to be unrelated to chemotherapy-associated profound neutropenia and occurred early after, or was the reason for, hospital admission. The antimicrobial susceptibility of the isolates varied: unlike previously reported cases, resistance in some of our isolates included aminoglycosides, newer fluoroquinolones, and trimethoprim-sulfamethoxazole. Despite in vitro susceptibility to imipenem in initial isolates, treatment of two patients with this agent obviously failed to eradicate the organism, and the patients either relapsed with bacteremia shortly after discontinuation of treatment or remained persistently febrile and bacteremic. O. anthropi appears to be increasingly recognized as a human opportunist pathogen associated with intravascular catheters and unpredictable multiple antibiotic resistance.
Kern
W V
WV
Abteilungen für Infektionskrankheiten und Hämatologie/Onkologie, Universitätsklinik und Poliklinik, Ulm, Germany.
Oethinger
M
M
Kaufhold
A
A
Rozdzinski
E
E
Marre
R
R
D000328:Adult; D000368:Aged; D000421:Alcaligenes / Q000187:drug effects / Q000302:isolation & purification*; D016470:Bacteremia / Q000188:drug therapy / Q000209:etiology*; D002675:Child, Preschool; D005260:Female; D006801:Humans; D008826:Microbial Sensitivity Tests; D008875:Middle Aged